Molecular design of multitarget neuroprotectors 3. Synthesis and bioactivity of tetrahydrocarbazole—aminoadamantane conjugates
Authors:
- 1 May 2016
- journal article
- research article
- Published by Springer Nature in Russian Chemical Bulletin
- Vol. 65 (5) , 1354-1359
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Molecular design of multitarget neuroprotectors 2. Synthesis and bioactivity of carbazole—γ-carboline conjugatesRussian Chemical Bulletin, 2016
- Modification of biologically active amides and amines with fluoro-containing heterocycles 11. Tetrahydrocarbazoles modified with 2-(5-fluoropyridin-3-yl)ethyl fragmentRussian Chemical Bulletin, 2014
- From Single Target to Multitarget/Network Therapeutics in Alzheimer’s TherapyPharmaceuticals, 2014
- Chronic Administration of Dimebon Ameliorates Pathology in Tau P301S Transgenic MiceJournal of Alzheimer’s Disease, 2013
- New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugsBritish Journal of Clinical Pharmacology, 2012
- Synthesis of 9-substituted 2,3,4,9-tetrahydro-1H-carbazole derivatives and evaluation of their anti-prion activity in TSE-infected cellsEuropean Journal of Medicinal Chemistry, 2011
- Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Diseases as Disease Modifying AgentsExperimental Neurobiology, 2010
- Hindering of proteinopathy-induced neurodegeneration as a new mechanism of action for neuroprotectors and cognition enhancing compoundsDoklady Biochemistry and Biophysics, 2009
- Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled studyThe Lancet, 2008
- Meta‐analysis of six‐month memantine trials in Alzheimer's diseaseAlzheimer's & Dementia, 2007